The analyses showed that COVID-19 patients with cardiovascular co-morbidities who also consumed statins had significantly lower plasma levels of IL-6 (adjusted p = 0.027), TNFα (adjusted p = 0.036), and IL-10 (adjusted p = 0.025) compared to COVID-19 patients with no CVD co-morbidities. Here, IL6 is linked to COVID-19.